Neuro-bio welcomes Georgia Price as part of the team! Georgia is currently undertaking a DPhil at the University of Oxford studying neurodegenerative diseases after completing her undergraduate degree in Biomedical Science from the University of Sheffield. After hearing Susan Greenfield give a talk on the exciting and novel work carried out at Neuro-Bio, she was keen to undertake a research placement at the company.
LATEST NEWS
- Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
- New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures